PrecisionLife

Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care.

🔗 precisionlife.com/blog-support...

#MECFS #LongCOVID

We fully support our partners at @actionforme.bsky.social in their response to the UK government's ME/CFS Delivery Plan as a positive and necessary step forward – but that much more is needed to deliver real change, faster, for people with ME. #pwME #MECFS #MyalgicE #MyalgicEncephalomyelitis

PrecisionLife | Blog | Mechanism-Based Precision Medicine Learn how mechanostics and mechanism-based precision medicine can transform the future of the UK NHS and healthcare globally - read the article.

Thanks Oevie. We’ve shown how this approach works in over 60 complex, chronic diseases including long COVID, ME/CFS, endometriosis, autoimmune conditions, ALS and type-II diabetes complications – with multiple clinical studies running. Further details in the article: precisionlife.com/future-now

YouTube video by Action For ME Genetics Centre of Excellence Webinar - 06 June 2025

1-hour recording from AfME’s Genetics Centre of Excellence webinar:

"Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project."

www.youtube.com/watch?v=zhNt...

#MEcfs #CFS #PwME

Chronic diseases overwhelm health systems, yet most lack accurate risk prediction or effective treatment. In a new insight article, our CEO explores how mechanism-based precision medicine can change that.

🔗 precisionlife.com/future-now

#PrecisionMedicine
#PrecisionLife

Functional genomics explainer: A strategic opportunity for the UK

Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare.

Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases.

🔗 bioindustry.org/resource-rep...

Watch our full presentation (clip below) in the recent @actionforme.bsky.social webinar on ME/CFS & long COVID.

We explore genetic risk factors, protective biology, and precision biomarkers that could transform diagnosis and treatment.

🎥 precisionlife.com/webinar-upda...

#MECFS #LongCOVID

PrecisionLife CEO, Steve Gardner, spoke yesterday on BBC Radio 4’s Today Show about the UK industrial strategy & why prioritizing life sciences is vital for economic growth.

#LifeSciences #PrecisionMedicine

ALS actively protective biology, novel causal targets and mechanistic biomarkers | PrecisionLife AI-led causative analysis identifies new actively protective biology, novel causal targets, drug repurposing candidates and mechanistic patient stratification biomarkers in ALS

Ahead of Global MND Awareness Day, we're sharing our recent work uncovering the mechanisms behind ALS, new protective biology, and a path to non-invasive, personalized diagnosis and treatment.

Read more: precisionlife.com/publication-...

#ALS #MND

New in Bio-IT World: how PrecisionLife is enabling mechanism-based precision medicine for complex diseases like ME/CFS, long COVID, ALS & endometriosis.

Read the article: www.bio-itworld.com/news/2025/06...

#precisionmedicine #biomarkers #PrecisionLife

⏰ Last chance to register!

Our webinar with @actionforme.bsky.social on #MECFS & #LongCOVID is tomorrow. Join for the latest research insights and their implications for the prediction, treatment and prevention of the conditions.

🔗 Register: precisionlife.com/webinar-upda...

#pwME #MyalgicE

Rowan Gardner (@rowanbio.bsky.social) joins global leaders at Oxford Nanopore’s (@nanoporetech.com) Informatics Day tomorrow to discuss how AI and genomics can unlock new insights in complex disease biology.

🔗 nanoporetech.com/about/events...

#LondonCalling25 #Genomics #AI #PrecisionMedicine

Webinar - Update on Recent ME/CFS Research | PrecisionLife Join PrecisionLife and partners for new insights into ME/CFS genomics, diagnostics, and patient stratification from the LOCOME research programme.

We will share and discuss the latest ME/CFS & Long COVID genetic findings in a free webinar on 6 June, hosted by @actionforme.bsky.social.

Speakers include Steve Gardner, Audrey Ryback, and Sonya Chowdhury.

🎟️ Register: precisionlife.com/webinar-upda...

#MECFS #LongCOVID #precisionmedicine

Heading to #WCE2025?

We'll be there sharing new insights into genetic risk, patient stratification & diagnostic tools for #endometriosis and #womenshealth.

Come meet us in Sydney & explore the future of #precisionmedicine.

🔗 precisionlife.com/news-and-eve...

🧬 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨: 𝗨𝗻𝗰𝗼𝘃𝗲𝗿𝗶𝗻𝗴 𝗡𝗲𝘄 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗠𝗘/𝗖𝗙𝗦 𝗮𝗻𝗱 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗

This month’s 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴 newsletter explores groundbreaking progress in our understanding of complex disease biology.

Read more here:
em.precisionlife.com/insights-may...

#PrecisionMedicine #PrecisionLife

🎥 𝗘𝘅𝗽𝗲𝗿𝘁 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:
We highly recommend watching Dr. Sayoni Das' presentation, #PrecisionMedicine for Long COVID and ME/CFS.

👉 𝗪𝗮𝘁𝗰𝗵 𝗵𝗲𝗿𝗲: precisionlife.com/hubfs/Video/...

Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis - Journal of Translational Medicine Background Long COVID is a debilitating chronic condition that has affected over 100 million people globally. It is characterized by a diverse array of symptoms, including fatigue, cognitive dysfuncti...

𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 𝗦𝗲𝘃𝗲𝗿𝗲 𝗮𝗻𝗱 𝗙𝗮𝘁𝗶𝗴𝘂𝗲 𝗗𝗼𝗺𝗶𝗻𝗮𝗻𝘁 #𝗟𝗼𝗻𝗴𝗖𝗢𝗩𝗜𝗗 𝗮𝗻𝗱 𝗖𝗼𝗺𝗺𝗼𝗻𝗮𝗹𝗶𝘁𝗶𝗲𝘀 𝘄𝗶𝘁𝗵 #𝗠𝗘𝗖𝗙𝗦: 73 novel genes associated with Long COVID, and shared mechanisms with ME/CFS.

translational-medicine.biomedcentral.com/articles/10....

Genetic risk factors for ME/CFS identified using combinatorial analysis - Journal of Translational Medicine Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease that lacks known pathogenesis, distinctive diagnostic criteria, and effective treatment options...

📄 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:
𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 #𝗠𝗘𝗖𝗙𝗦 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝗱 𝘂𝘀𝗶𝗻𝗴 𝗖𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗼𝗿𝗶𝗮𝗹 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀: 14 novel genetic associations, paving the way for precision medicine.

translational-medicine.biomedcentral.com/articles/10....

Through our innovative AI-led combinatorial analytics platform, we've identified the first reproducible genetic associations for these complex conditions, offering hope for millions affected worldwide.

Unraveling the Biological Drivers of ME and Long COVID | PrecisionLife We have identified different genetic mechanisms causing ME/CFS and long COVID and used this to stratify patients. Learn more about our research.

🔬 𝗠𝗘 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗠𝗘/𝗖𝗙𝗦 𝗮𝗻𝗱 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗

This #MEAwarenessWeek, we're proud to share our progress in understanding and treating #MECFS and #LongCOVID.

🔗 precisionlife.com/longcovid-me...

World ME Alliance graphic. Photo of a person led in bed with an eye mask & ear defenders on. Text in white from top to bottom: 'Myth vs Fact. The Myalgic Encephalomyelitis Edition. Myth: ME is a mental health condition. Fact: ME is a biological illness that disrupts the metabolism & impairs the brain, immune system & autonomic nervous system. What facts do you want the world to understand this World ME Day?'

1/4

Today is #WorldMEDay 🧡

We are supporting the World ME Alliance to help debunk 6 of the most common myths about ME & share the medical facts about ME that everyone should know

Unraveling the Biological Drivers of ME and Long COVID | PrecisionLife We have identified different genetic mechanisms causing ME/CFS and long COVID and used this to stratify patients. Learn more about our research.

This is precision medicine in action — made possible through our #LOCOME project and partnerships across the UK and US.

👉 Explore our first-year progress in this visual summary — and read the full report on our website: precisionlife.com/mecfs

We’re changing that.
🧬 We’ve identified novel genetic drivers of disease
🛡️ Discovered actively protective drug targets
🧪 Developed rapid, non-invasive diagnostic tools
💊 Initiated studies of repurposed, precision therapies
🎯 Enabled differential triage across overlapping syndromes

More than 400 million people worldwide have these debilitating conditions — yet there are no accurate diagnostic tools or effective treatments to treat the underlying causes.

📢 This #WorldMEDay, we’re proud to share real progress towards better outcomes for people living with ME/CFS and Long COVID.

Reproducibility of genetic risk factors identified for long COVID using combinatorial analysis across US and UK patient cohorts with diverse ancestries - Journal of Translational Medicine Background Long COVID is a major public health burden causing a diverse array of debilitating symptoms in tens of millions of patients globally. In spite of this overwhelming disease prevalence, stagg...

Reproducibility of Genetic Risk Factors for Long COVID Across Diverse Populations

translational-medicine.biomedcentral.com/articles/10....

#LongCOVID #MECFS #POTS #Genetics #DataScience #PrecisionMedicine

Genetic Risk Factors for Long COVID Reproduced Across Populations | PrecisionLife PrecisionLife study confirms reproducible genetic markers for long COVID in diverse cohorts, advancing diagnostic and treatment strategies for the disease.

PrecisionLife & Metrodora confirm the first reproducible genetic signatures for #LongCOVID across ancestries. Just in time for #WorldMEDay, this marks major progress for patients with complex chronic conditions.

🔗 Read: precisionlife.com/publication-...

#PrecisionMedicine #MECFS #Genomics

Reproducibility of genetic risk factors identified for long COVID using combinatorial analysis across US and UK patient cohorts with diverse ancestries - Journal of Translational Medicine Background Long COVID is a major public health burden causing a diverse array of debilitating symptoms in tens of millions of patients globally. In spite of this overwhelming disease prevalence, stagg...

Very proud of our team @precisionlife.bsky.social and our partners today translational-medicine.biomedcentral.com/articles/10....
Reproducing insights across populations
🧬🖥️

PrecisionLife at LSX World Congress Meet with PrecisionLife Co-founder Rowan Gardner at the LSX World Congress and join our panel discussion on increasing CNS and neurology R&D successes.

How can biotech and pharma partner more effectively in CNS & neurology? 🧠

Catch @rowanbio.bsky.social and leaders from Otsuka, Eli Lilly, Avata Biosciences & Lumina Life Sciences at LSX World Congress to share strategies for success.

#LSXWorld #CNS #Partnerships

precisionlife.com/news-and-eve...

We’re heading to Abu Dhabi Global Health Week to share how PrecisionLife is enabling th eprediction and prevention of major chronic diseases with groundbreaking insights into the mechanisms driving complex conditions. Let’s connect. 🌍
🔗 precisionlife.com/news-and-eve...
#ADGHW2025 #PrecisionMedicine